Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2022 16:20 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update

Amended Next Generation Capecitabine study has restarted which will elucidate timelines for de novo formation of DPDExpanded efforts for enrollment in PCS499PCS12852 on target to complete enrollment...